🔗 Visit the ClinicalTrials.gov page for NCT01392989
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies. | Front Immunol | 2015 | 0.88 |
| 2 | Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society. | J Hematol Oncol | 2015 | 0.88 |
| 3 | Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches. | Leukemia | 2014 | 0.86 |
| 4 | Cytokine-induced killer (CIK) cells: from basic research to clinical translation. | Chin J Cancer | 2015 | 0.78 |